SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000905718-20-000079
Filing Date
2020-01-30
Accepted
2020-01-30 16:29:16
Documents
2
Group Members
TARDIMED SCIENCES LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D biopharmx_sch13djan2020.htm SC 13D 73952
2 JOINT FILING AGREEMENT biopharmx_sch13dex1jan2020.htm EX-1 6437
  Complete submission text file 0000905718-20-000079.txt   81966
Mailing Address 115 NICHOLSON LANE SAN JOSE CA 95134
Business Address 115 NICHOLSON LANE SAN JOSE CA 95134 650-889-5020
BioPharmX Corp (Subject) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: SC 13D | Act: 34 | File No.: 005-87755 | Film No.: 20561736
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 TICE BOULEVARD, SUITE A26 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE A26 WOODCLIFF LAKE NJ 07677 201-645-4767
Timber Pharmaceuticals LLC (Filed by) CIK: 0001800689 (see all company filings)

IRS No.: 833743698 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D